INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

GABELLI & Co INVESTMENT ADVISERS, INC.'s Holding History (CIK: 0000932724)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 225,000 Value ($000) $221 Avg Close — Range —
Q2 2023
Shares 225,000 Value ($000) $180 Avg Close — Range —
Q1 2023
Shares 225,000 Value ($000) $187 Avg Close — Range —
Q4 2022
Shares 225,000 Value ($000) $170 Avg Close — Range —
Q3 2022
Shares 225,000 Value ($000) $170 Avg Close — Range —
Q2 2022
Shares 225,000 Value ($000) $144 Avg Close — Range —
Q1 2022
Shares 225,000 Value ($000) $138 Avg Close — Range —
Q4 2021
Shares 225,000 Value ($000) $136 Avg Close — Range —
Q3 2021
Shares 225,000 Value ($000) $136 Avg Close — Range —
Q2 2021
Shares 225,000 Value ($000) $154 Avg Close — Range —
Q1 2021
Shares 225,000 Value ($000) $145 Avg Close — Range —
Q4 2020
Shares 225,000 Value ($000) $137 Avg Close — Range —
Q3 2020
Shares 350,000 Value ($000) $243 Avg Close — Range —
Q2 2020
Shares 350,000 Value ($000) $252 Avg Close — Range —
Q1 2020
Shares 350,000 Value ($000) $304 Avg Close — Range —
Q4 2019
Shares 350,000 Value ($000) $465 Avg Close — Range —
Q3 2019
Shares 350,000 Value ($000) $318 Avg Close — Range —
Q2 2019
Shares 300,000 Value ($000) $300 Avg Close — Range —